Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Tissue-Specific Oxidative Stress Modulation by Exercise: A Comparison between MICT and HIIT in an Obese Rat Model.

Groussard C, Maillard F, Vazeille E, Barnich N, Sirvent P, Otero YF, Combaret L, Madeuf E, Sourdrille A, Delcros G, Etienne M, Teixeira A, Sauvanet P, Pialoux V, Boisseau N.

Oxid Med Cell Longev. 2019 Jul 14;2019:1965364. doi: 10.1155/2019/1965364. eCollection 2019.

2.

Heptylmannose-functionalized cellulose for the binding and specific detection of pathogenic E. coli.

Cauwel M, Sivignon A, Bridot C, Nongbe MC, Deniaud D, Roubinet B, Landemarre L, Felpin FX, Bouckaert J, Barnich N, Gouin SG.

Chem Commun (Camb). 2019 Sep 4;55(68):10158-10161. doi: 10.1039/c9cc05545b. Epub 2019 Aug 7.

PMID:
31389420
3.

New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.

Larabi A, Barnich N, Nguyen HTT.

Autophagy. 2019 Jul 9:1-14. doi: 10.1080/15548627.2019.1635384. [Epub ahead of print]

PMID:
31286804
4.

Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease.

Sokol H, Brot L, Stefanescu C, Auzolle C, Barnich N, Buisson A, Fumery M, Pariente B, Le Bourhis L, Treton X, Nancey S, Allez M, Seksik P; REMIND Study Group Investigators.

Gut. 2019 May 29. pii: gutjnl-2019-318719. doi: 10.1136/gutjnl-2019-318719. [Epub ahead of print]

PMID:
31142586
5.

High intensity interval training promotes total and visceral fat mass loss in obese Zucker rats without modulating gut microbiota.

Maillard F, Vazeille E, Sauvanet P, Sirvent P, Combaret L, Sourdrille A, Chavanelle V, Bonnet R, Otero YF, Delcros G, Barnich N, Boisseau N.

PLoS One. 2019 Apr 9;14(4):e0214660. doi: 10.1371/journal.pone.0214660. eCollection 2019.

6.

T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence.

Allez M, Auzolle C, Ngollo M, Bottois H, Chardiny V, Corraliza AM, Salas A, Perez K, Stefanescu C, Nancey S, Buisson A, Pariente B, Fumery M, Sokol H, Tréton X, Barnich N, Seksik P, Le Bourhis L; REMIND Study Group.

Gut. 2019 Feb 12. pii: gutjnl-2018-317878. doi: 10.1136/gutjnl-2018-317878. [Epub ahead of print]

PMID:
30792246
7.

Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts.

Delmas J, Gibold L, Faïs T, Batista S, Leremboure M, Sinel C, Vazeille E, Cattoir V, Buisson A, Barnich N, Dalmasso G, Bonnet R.

Sci Rep. 2019 Feb 18;9(1):2175. doi: 10.1038/s41598-019-38628-1.

8.

Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis.

Imai J, Kitamoto S, Sugihara K, Nagao-Kitamoto H, Hayashi A, Morhardt TL, Kuffa P, Higgins PDR, Barnich N, Kamada N.

Mucosal Immunol. 2019 May;12(3):632-643. doi: 10.1038/s41385-019-0138-4. Epub 2019 Feb 11.

9.

Crohn's Disease-Associated Adherent-Invasive Escherichia coli Manipulate Host Autophagy by Impairing SUMOylation.

Dalmasso G, Nguyen HTT, Faïs T, Massier S, Barnich N, Delmas J, Bonnet R.

Cells. 2019 Jan 9;8(1). pii: E35. doi: 10.3390/cells8010035.

10.

Preventive Effect of Spontaneous Physical Activity on the Gut-Adipose Tissue in a Mouse Model That Mimics Crohn's Disease Susceptibility.

Maillard F, Vazeille E, Sauvanet P, Sirvent P, Bonnet R, Combaret L, Chausse P, Chevarin C, Otero YF, Delcros G, Chavanelle V, Boisseau N, Barnich N.

Cells. 2019 Jan 9;8(1). pii: E33. doi: 10.3390/cells8010033.

11.

Efficient and reproducible experimental infections of rats with Blastocystis spp.

Defaye M, Nourrisson C, Baudu E, Warwzyniak I, Bonnin V, Bonnet M, Barnich N, Ardid D, Delbac F, Carvalho FA, Poirier P.

PLoS One. 2018 Nov 19;13(11):e0207669. doi: 10.1371/journal.pone.0207669. eCollection 2018.

12.

Deciphering the immune microenvironment of a tissue by digital imaging and cognition network.

Lopès A, Cassé AH, Billard E, Boulcourt-Sambou E, Roche G, Larois C, Barnich N, Naimi S, Bonnet M, Dumas B.

Sci Rep. 2018 Nov 12;8(1):16692. doi: 10.1038/s41598-018-34731-x.

13.

Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls.

Le Baut G, O'Brien C, Pavli P, Roy M, Seksik P, Tréton X, Nancey S, Barnich N, Bezault M, Auzolle C, Cazals-Hatem D, Viala J, Allez M; REMIND GROUP, Hugot JP, Dumay A.

Front Cell Infect Microbiol. 2018 Sep 21;8:336. doi: 10.3389/fcimb.2018.00336. eCollection 2018.

14.

AIEC infection triggers modification of gut microbiota composition in genetically predisposed mice, contributing to intestinal inflammation.

Bretin A, Lucas C, Larabi A, Dalmasso G, Billard E, Barnich N, Bonnet R, Nguyen HTT.

Sci Rep. 2018 Aug 17;8(1):12301. doi: 10.1038/s41598-018-30055-y.

15.

Microbial markers in colorectal cancer detection and/or prognosis.

Villéger R, Lopès A, Veziant J, Gagnière J, Barnich N, Billard E, Boucher D, Bonnet M.

World J Gastroenterol. 2018 Jun 14;24(22):2327-2347. doi: 10.3748/wjg.v24.i22.2327. Review.

16.

Anti-infectious properties of the probiotic Saccharomyces cerevisiae CNCM I-3856 on enterotoxigenic E. coli (ETEC) strain H10407.

Roussel C, Sivignon A, de Vallée A, Garrait G, Denis S, Tsilia V, Ballet N, Vandekerckove P, Van de Wiele T, Barnich N, Blanquet-Diot S.

Appl Microbiol Biotechnol. 2018 Jul;102(14):6175-6189. doi: 10.1007/s00253-018-9053-y. Epub 2018 May 25.

PMID:
29802478
17.

Oligomannose-Rich Membranes of Dying Intestinal Epithelial Cells Promote Host Colonization by Adherent-Invasive E. coli.

Dumych T, Yamakawa N, Sivignon A, Garenaux E, Robakiewicz S, Coddeville B, Bongiovanni A, Bray F, Barnich N, Szunerits S, Slomianny C, Herrmann M, Gouin SG, Lutsyk AD, Munoz LE, Lafont F, Rolando C, Bilyy R, Bouckaert JMJ.

Front Microbiol. 2018 Apr 18;9:742. doi: 10.3389/fmicb.2018.00742. eCollection 2018.

18.

Colibactin: More Than a New Bacterial Toxin.

Faïs T, Delmas J, Barnich N, Bonnet R, Dalmasso G.

Toxins (Basel). 2018 Apr 10;10(4). pii: E151. doi: 10.3390/toxins10040151. Review.

19.

Adaptation of adherent-invasive E. coli to gut environment: Impact on flagellum expression and bacterial colonization ability.

Sevrin G, Massier S, Chassaing B, Agus A, Delmas J, Denizot J, Billard E, Barnich N.

Gut Microbes. 2018 Mar 1:1-17. doi: 10.1080/19490976.2017.1421886. [Epub ahead of print]

PMID:
29494278
20.

Adherent-invasive Escherichia coli in inflammatory bowel disease.

Palmela C, Chevarin C, Xu Z, Torres J, Sevrin G, Hirten R, Barnich N, Ng SC, Colombel JF.

Gut. 2018 Mar;67(3):574-587. doi: 10.1136/gutjnl-2017-314903. Epub 2017 Nov 15. Review.

PMID:
29141957
21.

Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period.

Lashermes A, Boudieu L, Barbier J, Sion B, Gelot A, Barnich N, Ardid D, Carvalho FA.

Gut Microbes. 2018 Jan 2;9(1):26-37. doi: 10.1080/19490976.2017.1361091. Epub 2017 Oct 4.

22.

The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease.

Sivignon A, Bouckaert J, Bernard J, Gouin SG, Barnich N.

Expert Opin Ther Targets. 2017 Sep;21(9):837-847. doi: 10.1080/14728222.2017.1363184. Epub 2017 Aug 11. Review.

PMID:
28762293
23.

Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases.

Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.

J Clin Gastroenterol. 2018 Aug;52(7):e53-e62. doi: 10.1097/MCG.0000000000000837.

PMID:
28723856
24.

Microbiota, Inflammation and Colorectal Cancer.

Lucas C, Barnich N, Nguyen HTT.

Int J Mol Sci. 2017 Jun 20;18(6). pii: E1310. doi: 10.3390/ijms18061310. Review.

25.

Enterohemorrhagic Escherichia coli pathogenesis: role of Long polar fimbriae in Peyer's patches interactions.

Cordonnier C, Etienne-Mesmin L, Thévenot J, Rougeron A, Rénier S, Chassaing B, Darfeuille-Michaud A, Barnich N, Blanquet-Diot S, Livrelli V.

Sci Rep. 2017 Mar 20;7:44655. doi: 10.1038/srep44655.

26.

Physiochemical Tuning of Potent Escherichia coli Anti-Adhesives by Microencapsulation and Methylene Homologation.

Alvarez Dorta D, Chalopin T, Sivignon A, de Ruyck J, Dumych TI, Bilyy RO, Deniaud D, Barnich N, Bouckaert J, Gouin SG.

ChemMedChem. 2017 Jun 21;12(12):986-998. doi: 10.1002/cmdc.201700061. Epub 2017 Apr 10.

PMID:
28257558
27.

Bacteriophages Targeting Adherent Invasive Escherichia coli Strains as a Promising New Treatment for Crohn's Disease.

Galtier M, De Sordi L, Sivignon A, de Vallée A, Maura D, Neut C, Rahmouni O, Wannerberger K, Darfeuille-Michaud A, Desreumaux P, Barnich N, Debarbieux L.

J Crohns Colitis. 2017 Jul 1;11(7):840-847. doi: 10.1093/ecco-jcc/jjw224.

28.

Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer.

Gagnière J, Bonnin V, Jarrousse AS, Cardamone E, Agus A, Uhrhammer N, Sauvanet P, Déchelotte P, Barnich N, Bonnet R, Pezet D, Bonnet M.

Clin Sci (Lond). 2017 Mar 1;131(6):471-485. doi: 10.1042/CS20160876. Epub 2017 Jan 16.

PMID:
28093453
29.

Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease.

Buisson A, Bringer MA, Barnich N, Vazeille E.

Inflamm Bowel Dis. 2016 Dec;22(12):2943-2955. Review.

PMID:
27824652
30.

Exosomes: From Functions in Host-Pathogen Interactions and Immunity to Diagnostic and Therapeutic Opportunities.

Carrière J, Barnich N, Nguyen HT.

Rev Physiol Biochem Pharmacol. 2016;172:39-75. Review.

PMID:
27600934
31.

Oral exposure to environmental pollutant benzo[a]pyrene impacts the intestinal epithelium and induces gut microbial shifts in murine model.

Ribière C, Peyret P, Parisot N, Darcha C, Déchelotte PJ, Barnich N, Peyretaillade E, Boucher D.

Sci Rep. 2016 Aug 9;6:31027. doi: 10.1038/srep31027.

32.

Association of colorectal cancer with pathogenic Escherichia coli: Focus on mechanisms using optical imaging.

Veziant J, Gagnière J, Jouberton E, Bonnin V, Sauvanet P, Pezet D, Barnich N, Miot-Noirault E, Bonnet M.

World J Clin Oncol. 2016 Jun 10;7(3):293-301. doi: 10.5306/wjco.v7.i3.293.

33.

Comparative genomics of Crohn's disease-associated adherent-invasive Escherichia coli.

O'Brien CL, Bringer MA, Holt KE, Gordon DM, Dubois AL, Barnich N, Darfeuille-Michaud A, Pavli P.

Gut. 2017 Aug;66(8):1382-1389. doi: 10.1136/gutjnl-2015-311059. Epub 2016 Apr 20.

34.

Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn's disease.

Chalopin T, Alvarez Dorta D, Sivignon A, Caudan M, Dumych TI, Bilyy RO, Deniaud D, Barnich N, Bouckaert J, Gouin SG.

Org Biomol Chem. 2016 Apr 28;14(16):3913-25. doi: 10.1039/c6ob00424e. Epub 2016 Apr 4.

PMID:
27043998
35.

Differentiation of Crohn's Disease-Associated Isolates from Other Pathogenic Escherichia coli by Fimbrial Adhesion under Shear Force.

Szunerits S, Zagorodko O, Cogez V, Dumych T, Chalopin T, Alvarez Dorta D, Sivignon A, Barnich N, Harduin-Lepers A, Larroulet I, Yanguas Serrano A, Siriwardena A, Pesquera A, Zurutuza A, Gouin SG, Boukherroub R, Bouckaert J.

Biology (Basel). 2016 Apr 1;5(2). pii: E14. doi: 10.3390/biology5020014.

36.

Activation of the EIF2AK4-EIF2A/eIF2α-ATF4 pathway triggers autophagy response to Crohn disease-associated adherent-invasive Escherichia coli infection.

Bretin A, Carrière J, Dalmasso G, Bergougnoux A, B'chir W, Maurin AC, Müller S, Seibold F, Barnich N, Bruhat A, Darfeuille-Michaud A, Nguyen HT.

Autophagy. 2016 May 3;12(5):770-83. doi: 10.1080/15548627.2016.1156823. Epub 2016 Mar 17.

37.

Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.

Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.

Aliment Pharmacol Ther. 2016 May;43(10):1069-79. doi: 10.1111/apt.13585. Epub 2016 Mar 8.

38.

The Antiadhesive Strategy in Crohn's Disease: Orally Active Mannosides to Decolonize Pathogenic Escherichia coli from the Gut.

Alvarez Dorta D, Sivignon A, Chalopin T, Dumych TI, Roos G, Bilyy RO, Deniaud D, Krammer EM, de Ruyck J, Lensink MF, Bouckaert J, Barnich N, Gouin SG.

Chembiochem. 2016 May 17;17(10):936-52. doi: 10.1002/cbic.201600018. Epub 2016 Apr 8.

PMID:
26946458
39.

[How some commensal bacteria would exacerbate colorectal carcinogenesis?].

Raisch J, Dalmasso G, Bonnet R, Barnich N, Bonnet M, Bringer MA.

Med Sci (Paris). 2016 Feb;32(2):175-82. doi: 10.1051/medsci/20163202011. Epub 2016 Mar 2. Review. French.

40.

Gut microbiota imbalance and colorectal cancer.

Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, Bringer MA, Pezet D, Bonnet M.

World J Gastroenterol. 2016 Jan 14;22(2):501-18. doi: 10.3748/wjg.v22.i2.501. Review.

41.

Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation.

Agus A, Denizot J, Thévenot J, Martinez-Medina M, Massier S, Sauvanet P, Bernalier-Donadille A, Denis S, Hofman P, Bonnet R, Billard E, Barnich N.

Sci Rep. 2016 Jan 8;6:19032. doi: 10.1038/srep19032.

42.

Exosomes Released from Cells Infected with Crohn's Disease-associated Adherent-Invasive Escherichia coli Activate Host Innate Immune Responses and Enhance Bacterial Intracellular Replication.

Carrière J, Bretin A, Darfeuille-Michaud A, Barnich N, Nguyen HT.

Inflamm Bowel Dis. 2016 Mar;22(3):516-28. doi: 10.1097/MIB.0000000000000635.

PMID:
26595556
43.

Development of Heptylmannoside-Based Glycoconjugate Antiadhesive Compounds against Adherent-Invasive Escherichia coli Bacteria Associated with Crohn's Disease.

Sivignon A, Yan X, Alvarez Dorta D, Bonnet R, Bouckaert J, Fleury E, Bernard J, Gouin SG, Darfeuille-Michaud A, Barnich N.

MBio. 2015 Nov 17;6(6):e01298-15. doi: 10.1128/mBio.01298-15.

44.

GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.

Vazeille E, Chassaing B, Buisson A, Dubois A, de Vallée A, Billard E, Neut C, Bommelaer G, Colombel JF, Barnich N, Darfeuille-Michaud A, Bringer MA.

Inflamm Bowel Dis. 2016 Jan;22(1):68-81. doi: 10.1097/MIB.0000000000000609.

PMID:
26512715
45.

The Vat-AIEC protease promotes crossing of the intestinal mucus layer by Crohn's disease-associated Escherichia coli.

Gibold L, Garenaux E, Dalmasso G, Gallucci C, Cia D, Mottet-Auselo B, Faïs T, Darfeuille-Michaud A, Nguyen HT, Barnich N, Bonnet R, Delmas J.

Cell Microbiol. 2016 May;18(5):617-31. doi: 10.1111/cmi.12539. Epub 2015 Nov 23.

PMID:
26499863
46.

Inhibition profiles of mono- and polyvalent FimH antagonists against 10 different Escherichia coli strains.

Chalopin T, Brissonnet Y, Sivignon A, Deniaud D, Cremet L, Barnich N, Bouckaert J, Gouin SG.

Org Biomol Chem. 2015 Dec 14;13(46):11369-75. doi: 10.1039/c5ob01581b.

PMID:
26440382
47.

Correction for Dreux et al., Ribonucleotide Reductase Repressor NrdR as a Novel Regulator for Motility and Chemotaxis during Adherent-Invasive Escherichia coli Infection.

Dreux N, Cendra Mdel M, Massier S, Darfeuille-Michaud A, Barnich N, Torrents E.

Infect Immun. 2015 Oct;83(10):4174. doi: 10.1128/IAI.00728-15. No abstract available.

48.

Brilliant glyconanocapsules for trapping of bacteria.

Yan X, Sivignon A, Alcouffe P, Burdin B, Favre-Bonté S, Bilyy R, Barnich N, Fleury E, Ganachaud F, Bernard J.

Chem Commun (Camb). 2015 Aug 28;51(67):13193-6. doi: 10.1039/c5cc04653j.

PMID:
26194620
49.

Glycopolymers as Antiadhesives of E. coli Strains Inducing Inflammatory Bowel Diseases.

Yan X, Sivignon A, Yamakawa N, Crepet A, Travelet C, Borsali R, Dumych T, Li Z, Bilyy R, Deniaud D, Fleury E, Barnich N, Darfeuille-Michaud A, Gouin SG, Bouckaert J, Bernard J.

Biomacromolecules. 2015 Jun 8;16(6):1827-36. doi: 10.1021/acs.biomac.5b00413. Epub 2015 May 22.

PMID:
25961760
50.

Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profile.

Vazeille E, Buisson A, Bringer MA, Goutte M, Ouchchane L, Hugot JP, de Vallée A, Barnich N, Bommelaer G, Darfeuille-Michaud A.

J Crohns Colitis. 2015 May;9(5):410-20. doi: 10.1093/ecco-jcc/jjv053. Epub 2015 Mar 24.

PMID:
25805890

Supplemental Content

Loading ...
Support Center